$198.09+0.05%Close 17 Nov 2026 · Market value $30.17B
In its results release of 29 Oct 2026 (Q3 FY2026), Illumina gave 1 forecast in figures, among them organic revenue growth of at least +4% for FY2026.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 29 Oct 2026
| Measure | Period | Guidance | As stated |
|---|
| Organic revenue growth | FY2026 | At least +4% | Organic revenue growth greater than 4% and ROW organic revenue growth greater than 5%, both unchanged versus prior guidance. |
|---|
Source: the company's earnings release.
Guidance against results last two years
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| Revenue | FY2026 | $4.60B to $4.64B | Raised once | — | To come |
|---|
| Revenue growth | FY2026 | +4% to +6% | Given once | — | To come |
|---|
| Organic revenue growth | FY2026 | At least +4% | Given once | — | To come |
|---|
| EPS · Adjusted | FY2026 | $5.30 to $5.40 | Raised once | — | To come |
|---|
| Operating margin · Adjusted | FY2026 | 23.4% to 23.6% | Raised once | — | To come |
|---|
ILMN in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.